
BAKER BROS. ADVISORS LP
Latest 13F filing data - Q3 2025
Holdings (Top positions)
| Stock | Ticker | ||
|---|---|---|---|
![]() | ALMS | 1.56M | $6.23M |
![]() | GPCR | 1.56M | $43.57M |
![]() | RAPP | 1.55M | $45.95M |
![]() | DBVT | 1.46M | $14.61M |
![]() | SKYE | 1.45M | $5.70M |
![]() | RLAY | 1.16M | $6.06M |
![]() | XNCR | 1.10M | $12.93M |
![]() | VTYX | 1.02M | $3.18M |
![]() | SYRE | 1.00M | $16.76M |
![]() | NGNE | 992K | $17.19M |
![]() | KALA | 985K | $1.51M |
![]() | SGMT | 953K | $6.54M |
![]() | ABVX | 876K | $74.36M |
![]() | VYNE | 851K | $285.20K |
![]() | SRZNW | 833K | $14.83K |
![]() | DNTH | 790K | $31.08M |
![]() | PRAX | 689K | $36.54M |
![]() | CLDX | 665K | $17.21M |
![]() | PCVX | 641K | $23.08M |
![]() | RNA | 625K | $27.23M |

Alumis Inc. Common Stock
ALMS
Shares Held
1.56M
Value
$6.23M

Structure Therapeutics Inc.
GPCR
Shares Held
1.56M
Value
$43.57M

Rapport Therapeutics, Inc. Common Stock
RAPP
Shares Held
1.55M
Value
$45.95M

DBV Technologies S.A.
DBVT
Shares Held
1.46M
Value
$14.61M

Skye Bioscience, Inc.
SKYE
Shares Held
1.45M
Value
$5.70M

Relay Therapeutics, Inc.
RLAY
Shares Held
1.16M
Value
$6.06M

Xencor, Inc.
XNCR
Shares Held
1.10M
Value
$12.93M

Ventyx Biosciences, Inc.
VTYX
Shares Held
1.02M
Value
$3.18M

Spyre Therapeutics, Inc.
SYRE
Shares Held
1.00M
Value
$16.76M

Neurogene Inc.
NGNE
Shares Held
992K
Value
$17.19M

KALA BIO, Inc.
KALA
Shares Held
985K
Value
$1.51M

Sagimet Biosciences Inc.
SGMT
Shares Held
953K
Value
$6.54M

Abivax S.A.
ABVX
Shares Held
876K
Value
$74.36M

VYNE Therapeutics Inc.
VYNE
Shares Held
851K
Value
$285.20K

Surrozen, Inc.
SRZNW
Shares Held
833K
Value
$14.83K

Dianthus Therapeutics, Inc.
DNTH
Shares Held
790K
Value
$31.08M

Praxis Precision Medicines, Inc.
PRAX
Shares Held
689K
Value
$36.54M

Celldex Therapeutics, Inc.
CLDX
Shares Held
665K
Value
$17.21M

Vaxcyte, Inc.
PCVX
Shares Held
641K
Value
$23.08M

Avidity Biosciences, Inc.
RNA
Shares Held
625K
Value
$27.23M
